Could EGPA be Treated with Biologics?

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

January 11, 2019

Feat. T. Murphy

Feat. S. Gawchik

Cleveland Clinic Rheumatology

EADV 2023 Insights

Cleveland Clinic Rheumatology

Cleveland Clinic Rheumatology

Cleveland Clinic Rheumatology

A. Villa-Forte

EULAR 2023 Insights

Cleveland Clinic Rheumatology

Cleveland Clinic Rheumatology

Hospital for Special Surgery

Cleveland Clinic Rheumatology

A. Villa-Forte

Evidence-Based Hair

Fatima Al Naimat

Hospital for Special Surgery

R. Spiera, P. Seo

Haner Direskeneli

Yusuf Yazici

Houston Methodist DeBakey Heart and Vascular Center

Login

Login

Join VuMedi

Could EGPA be Treated with Biologics?

Expert Perspectives on CSU

Shared Voices in the CSU Community

Recommended

New and Emerging Treatments in Cutaneous Vasculitis

Checkpoint Inhibitors and Rheumatic Disease

EADV 2023 Insights: Infectious Granulomatous Skin Diseases

When Should Biologic Agents be Considered in Eosinophilic Granulomat…

EGPA: Challenges and Prognosis

Eosinophilic Granulomatosis with Polyangiitis with Persistent Shortn…

EULAR 2023 Insights: Benralizumab for Eosinophilic Granulomatosis wi…

Immunomodulatory Drugs (IMIDs) Advances in Disease Pathogenesis

EGPA: Look Carefully at the Heart

Eosinophilic Granulomatosis with Polyangiitis

Lupus And a New FDA Approval for EGPA

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Pathergy in Patients with Bechet's Disease Receiving Laser Hair Remo…

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Behçet Syndrome Diagnosis: How and When Do Major/Minor Clinical Mani…

Behcet Syndrome Update: How Does It Manifest? When Do Symptoms Typic…

Diagnosis of Giant Cell Arteritis

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

GCA & Steroid Weaning